Chronic constipation and constipation-predominant IBS: Separate and distinct disorders or a spectrum of disease?

Gastroenterology and Hepatology

Volumn 12, Issue 3, 2016, Pages 171-178

  Siah, Kewin T H ^a,b   Wong, Reuben K ^b   Whitehead, William E ^c  

^a NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Balloon evacuation test; Colonic transit time; Dyssynergic defecation; Functional constipation; Irritable bowel syndrome; Visceral hypersensitivity

Indexed keywords

ANTIDEPRESSANT AGENT; BILE ACID TRANSPORTER INHIBITOR; GASTROINTESTINAL AGENT; LAXATIVE; LINACLOTIDE; LUBIPROSTONE; PREBIOTIC AGENT; PROBIOTIC AGENT; PRUCALOPRIDE; SPASMOLYTIC AGENT; TEGASEROD; UNCLASSIFIED DRUG; VELUSETRAG;

ANAL CANAL; ARTICLE; BALLOON; CHRONIC CONSTIPATION; COGNITIVE THERAPY; CONSTIPATION; DIETARY FIBER; ELECTROMYOGRAPHY; FECAL MICROBIOTA TRANSPLANTATION; HUMAN; HYPERSENSITIVITY; IRRITABLE COLON; SYMPTOM; TREATMENT RESPONSE; VISCERAL PAIN;

EID: 84961828604     PISSN: 15547914     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterology. 2006; 130(5): 1480-1491.
2. Wong RK, Palsson OS, Turner MJ, et al. Inability of the Rome III criteria to distinguish functional constipation from constipation-subtype irritable bowel syndrome. Am J Gastroenterol. 2010; 105(10): 2228-2234.
3. Rey E, Balboa A, Mearin F. Chronic constipation, irritable bowel syndrome with constipation and constipation with pain/discomfort: similarities and differences. Am J Gastroenterol. 2014; 109(6): 876-884.
4. Shekhar C, Monaghan PJ, Morris J, et al. Rome III functional constipation and irritable bowel syndrome with constipation are similar disorders within a spectrum of sensitization, regulated by serotonin. Gastroenterology. 2013; 145(4): 749-757; quiz e13-e14.
5. Zhao Y F, Ma XQ, Wang R, et al. Epidemiology of functional constipation and comparison with constipation-predominant irritable bowel syndrome: the Systematic Investigation of Gastrointestinal Diseases in China (SILC). Aliment Pharmacol Ther. 2011; 34(8): 1020-1029.
6. Heidelbaugh JJ, Stelwagon M, Miller SA, Shea E P, Chey WD. The spectrum of constipation-predominant irritable bowel syndrome and chronic idiopathic constipation: US survey assessing symptoms, care seeking, and disease burden. Am J Gastroenterol. 2015; 110(4): 580-587.
7. Bharucha AE, Locke GR, Zinsmeister AR, et al. Differences between painless and painful constipation among community women. Am J Gastroenterol. 2006; 101(3): 604-612.
8. Drossman DA, Morris C, Hu Y, et al. Further characterization of painful constipation (PC): clinical features over one year and comparison with IBS. J Clin Gastroenterol. 2008; 42(10): 1080-1088.
9. Koloski NA, Jones M, Young M, Talley NJ. Differentiation of functional constipation and constipation predominant irritable bowel syndrome based on Rome III criteria: a population-based study. Aliment Pharmacol Ther. 2015; 41(9): 856-866.
10. Nellesen D, Chawla A, Oh DL, Weissman T, Lavins BJ, Murray CW. Comorbidities in patients with irritable bowel syndrome with constipation or chronic idiopathic constipation: a review of the literature from the past decade. Postgrad Med. 2013; 125(2): 40-50.
11. Bharucha AE, Dorn SD, Lembo A, Pressman A; American Gastroenterological Association. American Gastroenterological Association medical position statement on constipation. Gastroenterology. 2013; 144(1): 211-217.
12. Chiarioni G, Kim SM, Vantini I, Whitehead WE. Validation of the balloon evacuation test: reproducibility and agreement with findings from anorectal manom-etry and electromyography. Clin Gastroenterol Hepatol. 2014; 12(12): 2049-2054.
13. Lembo A, Camilleri M. Chronic constipation. N Engl J Med. 2003; 349(14): 1360-1368.
14. Nyam DC, Pemberton JH, Ilstrup DM, Rath DM. Long-term results of surgery for chronic constipation. Dis Colon Rectum. 1997; 40(3): 273-279.
15. Chiarioni G, Kim SM, Whitehead WE. Overlap of IBS with normal transit constipation but not dyssynergic defecation. Gastroenterology. 2013; 144(5 suppl 1): S-726.
16. Bouin M, Plourde V, Boivin M, et al. Rectal distention testing in patients with irritable bowel syndrome: sensitivity, specificity, and predictive values of pain sensory thresholds. Gastroenterology. 2002; 122(7): 1771-1777.
17. Suttor V P, Prott GM, Hansen RD, Kellow JE, Malcolm A. Evidence for pelvic floor dyssynergia in patients with irritable bowel syndrome. Dis Colon Rectum. 2010; 53(2): 156-160.
18. Ansari R, Sohrabi S, Ghanaie O, et al. Comparison of colonic transit time between patients with constipation-predominant irritable bowel syndrome and functional constipation. Indian J Gastroenterol. 2010; 29(2): 66-68.
19. Manabe N, Wong BS, Camilleri M, Burton D, McKinzie S, Zinsmeister AR. Lower functional gastrointestinal disorders: evidence of abnormal colonic transit in a 287 patient cohort. Neurogastroenterol Motil. 2010; 22(3): 293-e82.
20. Törnblom H, Van Oudenhove L, Sadik R, Abrahamsson H, Tack J, Simrén M. Colonic transit time and IBS symptoms: what's the link? Am J Gastroenterol. 2012; 107(5): 754-760.
21. Mertz H, Naliboff B, Mayer EA. Symptoms and physiology in severe chronic constipation. Am J Gastroenterol. 1999; 94(1): 131-138.
22. Chiarioni G, Salandini L, Whitehead WE. Biofeedback benefits only patients with outlet dysfunction, not patients with isolated slow transit constipation. Gastroenterology. 2005; 129(1): 86-97.
23. Chiarioni G, Whitehead WE, Pezza V, Morelli A, Bassotti G. Biofeedback is superior to laxatives for normal transit constipation due to pelvic floor dyssynergia. Gastroenterology. 2006; 130(3): 657-664.
24. Bohn L, Storsrud S, Liljebo T, et al. Diet low in FODMAPs reduces symptoms of irritable bowel syndrome as well as traditional dietary advice: a randomized controlled trial. Gastroenterology. 2015; 149(6): 1399-1407.e2.
25. Halmos E P, Power VA, Shepherd SJ, Gibson PR, Muir JG. A diet low in FODMAPs reduces symptoms of irritable bowel syndrome. Gastroenterology. 2014; 146(1): 67-75.e5.
26. Biesiekierski JR, Peters SL, Newnham ED, Rosella O, Muir JG, Gibson PR. No effects of gluten in patients with self-reported non-celiac gluten sensitivity after dietary reduction of fermentable, poorly absorbed, short-chain carbohydrates. Gastroenterology. 2013; 145(2): 320-328.e1-e3.
27. Ruepert L, Quartero AO, de Wit NJ, van der Heijden GJ, Rubin G, Muris JW. Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome. Cochrane Database Syst Rev. 2011; (8): CD003460.
28. Moayyedi P, Ford AC, Talley NJ, et al. The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review. Gut. 2010; 59(3): 325-332.
29. Ford AC, Moayyedi P, Lacy BE, et al.; Task Force on the Management of Functional Bowel Disorders. American College of Gastroenterology monograph on the management of irritable bowel syndrome and chronic idiopathic constipation. Am J Gastroenterol. 2014; 109(suppl 1): s2-s26; quiz s27.
30. Kamm MA, Müller-Lissner S, Talley NJ, et al. Tegaserod for the treatment of chronic constipation: a randomized, double-blind, placebo-controlled multinational study. Am J Gastroenterol. 2005; 100(2): 362-372.
31. Chey WD, Lembo AJ, Lavins BJ, et al. Linaclotide for irritable bowel syndrome with constipation: a 26-week, randomized, double-blind, placebo-controlled trial to evaluate efficacy and safety. Am J Gastroenterol. 2012; 107(11): 1702-1712.
32. Chey WD, Camilleri M, Chang L, Rikner L, Graffner H. A randomized placebo-controlled phase IIb trial of a3309, a bile acid transporter inhibitor, for chronic idiopathic constipation. Am J Gastroenterol. 2011; 106(10): 1803-1812.
33. Wong BS, Camilleri M. Elobixibat for the treatment of constipation. Expert Opin Investig Drugs. 2013; 22(2): 277-284.
34. Ford AC, Talley NJ, Spiegel BM, et al. Effect of fibre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome: systematic review and meta-analysis. BMJ. 2008; 337:a2313.
35. Ford AC, Talley NJ, Schoenfeld PS, Quigley EM, Moayyedi P. Efficacy of anti-depressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis. Gut. 2009; 58(3): 367-378.
36. Chiarioni G, Nardo A, Vantini I, Romito A, Whitehead WE. Biofeedback is superior to electrogalvanic stimulation and massage for treatment of levator ani syndrome. Gastroenterology. 2010; 138(4): 1321-1329.